Gene: ADPGK
Official Full Name: ADP dependent glucokinaseprovided by HGNC
Gene Summary: ADPGK (EC 2.7.1.147) catalyzes the ADP-dependent phosphorylation of glucose to glucose-6-phosphate and may play a role in glycolysis, possibly during ischemic conditions (Ronimus and Morgan, 2004 [PubMed 14975750]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04771 | ADPGK Knockout cell line (HeLa) | Human | ADPGK | 1:3~1:6 | Negative | Online Inquiry |
KO04772 | ADPGK Knockout cell line (HCT 116) | Human | ADPGK | 1:2~1:4 | Negative | Online Inquiry |
KO04773 | ADPGK Knockout cell line (HEK293) | Human | ADPGK | 1:3~1:6 | Negative | Online Inquiry |
KO04774 | ADPGK Knockout cell line (A549) | Human | ADPGK | 1:3~1:4 | Negative | Online Inquiry |
ADPGK Gene Knockout Cell Lines are highly specialized cellular models designed to facilitate the exploration of adenosine diphosphate glucose kinase (ADPGK) function and its implications in metabolic processes. By employing CRISPR-Cas9 genome editing technology, these cell lines exhibit a complete knockout of the ADPGK gene, providing an invaluable tool for dissecting its biological role and resultant phenotypic alterations.
The primary function of ADPGK is to catalyze the conversion of adenosine diphosphate (ADP) and glucose-1-phosphate to adenosine triphosphate (ATP) and glucose-6-phosphate, central to glucose metabolism and cellular energy homeostasis. By utilizing these knockout models, researchers can assess alterations in metabolic pathways, cellular energetics, and functionality across various tissues, leading to deeper insights into the physiological and pathological roles of ADPGK.
The scientific importance of ADPGK Gene Knockout Cell Lines extends to both basic and translational research. In clinical settings, they can provide crucial information for understanding diseases characterized by metabolic dysregulation, contributing to the development of targeted therapies. These models are instrumental in drug discovery, enabling high-throughput screening for compounds that modulate ADPGK activity or downstream metabolic effects.
What sets our ADPGK Gene Knockout Cell Lines apart from alternatives is their precise and efficient genetic modification, validated through robust genotyping methods. This quality ensures that researchers are working with reliable and reproducible models. Furthermore, our cell lines can be customized for various applications, offering flexibility in experimental designs that other generalized models cannot match.
Investing in ADPGK Gene Knockout Cell Lines equips researchers and clinicians with a powerful resource to unlock the complexities of glucose metabolism and its associated disorders. Our company's extensive expertise in cellular and molecular biology, combined with a commitment to delivering high-quality biological products, positions us as a trusted partner in advancing scientific research and clinical solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.